Literature DB >> 17488972

Thyroid status during skeletal development determines adult bone structure and mineralization.

J H Duncan Bassett1, Kristina Nordström, Alan Boyde, Peter G T Howell, Shane Kelly, Björn Vennström, Graham R Williams.   

Abstract

Childhood hypothyroidism delays ossification and bone mineralization, whereas adult thyrotoxicosis causes osteoporosis. To determine how effects of thyroid hormone (T3) during development manifest in adult bone, we characterized TRalpha1(+/m)beta(+/-) mice, which express a mutant T3 receptor (TR) alpha1 with dominant-negative properties due to reduced ligand-binding affinity. Remarkably, adult TRalpha1(+/m)beta(+/-) mice had osteosclerosis with increased bone mineralization even though juveniles had delayed ossification. This phenotype was partially normalized by transient T3 treatment of juveniles and fully reversed in compound TRalpha1(+/m)beta(-/-) mutant mice due to 10-fold elevated hormone levels that allow the mutant TRalpha1 to bind T3. By contrast, deletion of TRbeta in TRalpha1(+/+)beta(-/ -) mice, which causes a 3-fold increase of hormone levels, led to osteoporosis in adults but advanced ossification in juveniles. T3-target gene analysis revealed skeletal hypothyroidism in TRalpha1(m/+)beta(+/-) mice, thyrotoxicosis in TRalpha1(+/+)beta(-/-) mice, and euthyroidism in TRalpha1(+/)beta(-/-) double mutants. Thus, TRalpha1 regulates both skeletal development and adult bone maintenance, with euthyroid status during development being essential to establish normal adult bone structure and mineralization.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17488972     DOI: 10.1210/me.2007-0157

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  40 in total

Review 1.  The role of FSH and TSH in bone loss and its clinical relevance.

Authors:  Manasi Agrawal; Guangyu Zhu; Li Sun; Mone Zaidi; Jameel Iqbal
Journal:  Curr Osteoporos Rep       Date:  2010-12       Impact factor: 5.096

2.  Optimal bone strength and mineralization requires the type 2 iodothyronine deiodinase in osteoblasts.

Authors:  J H Duncan Bassett; Alan Boyde; Peter G T Howell; Richard H Bassett; Thomas M Galliford; Marta Archanco; Holly Evans; Michelle A Lawson; Peter Croucher; Donald L St Germain; Valerie Anne Galton; Graham R Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-05       Impact factor: 11.205

Review 3.  Role and Mechanisms of Actions of Thyroid Hormone on the Skeletal Development.

Authors:  Ha-Young Kim; Subburaman Mohan
Journal:  Bone Res       Date:  2013-06-28       Impact factor: 13.567

4.  Hypermetabolism in mice caused by the central action of an unliganded thyroid hormone receptor alpha1.

Authors:  Maria Sjögren; Anneke Alkemade; Jens Mittag; Kristina Nordström; Abram Katz; Björn Rozell; Håkan Westerblad; Anders Arner; Björn Vennström
Journal:  EMBO J       Date:  2007-10-11       Impact factor: 11.598

Review 5.  Physiological consequences of the TRalpha1 aporeceptor state.

Authors:  Jens Mittag; Karin Wallis; Björn Vennström
Journal:  Heart Fail Rev       Date:  2008-11-14       Impact factor: 4.214

6.  Advanced bone formation in mice with a dominant-negative mutation in the thyroid hormone receptor β gene due to activation of Wnt/β-catenin protein signaling.

Authors:  Patrick J O'Shea; Dong Wook Kim; John G Logan; Sean Davis; Robert L Walker; Paul S Meltzer; Sheue-yann Cheng; Graham R Williams
Journal:  J Biol Chem       Date:  2012-03-22       Impact factor: 5.157

7.  Organ-Specific Requirements for Thyroid Hormone Receptor Ensure Temporal Coordination of Tissue-Specific Transformations and Completion of Xenopus Metamorphosis.

Authors:  Yuki Shibata; Luan Wen; Morihiro Okada; Yun-Bo Shi
Journal:  Thyroid       Date:  2020-01-23       Impact factor: 6.568

Review 8.  Clinical Consequences of Mutations in Thyroid Hormone Receptor-α1.

Authors:  Alies A van Mullem; Theo J Visser; Robin P Peeters
Journal:  Eur Thyroid J       Date:  2014-03-14

9.  Iodothyronine deiodinase enzyme activities in bone.

Authors:  Allan J Williams; Helen Robson; Monique H A Kester; Johannes P T M van Leeuwen; Stephen M Shalet; Theo J Visser; Graham R Williams
Journal:  Bone       Date:  2008-04-04       Impact factor: 4.398

10.  Osteo-chondroprogenitor-specific deletion of the selenocysteine tRNA gene, Trsp, leads to chondronecrosis and abnormal skeletal development: a putative model for Kashin-Beck disease.

Authors:  Charlene M Downey; Chelsea R Horton; Bradley A Carlson; Trish E Parsons; Dolph L Hatfield; Benedikt Hallgrímsson; Frank R Jirik
Journal:  PLoS Genet       Date:  2009-08-21       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.